Entelos stages comeback bid with funding

Back out of bankruptcy, modeling and simulation software company Entelos has recapitalized its business and brought on a new investor, the San Mateo, CA-based company said last week. The company, which emerged from bankruptcy in September, provides predictive technologies that aid in the development of drugs, healthcare products, foods and consumer products. Private equity investors Clearlake Capital Group and Imperium Partners Group are backing Entelos in its recent financing. The new funding will be used for product development and marketing efforts, according to the company. Article | Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.